Scientists invent biodegradable battery that controls the beating of hearts

‘Soft’ droplet battery is the first of its kind and has already been used to control mouse hearts

Anthony Cuthbertson
Friday 25 October 2024 11:21 BST
Comments
The tiny battery features capabilities useful for biomedical applications, including powering drug molecule release and heart defibrillation
The tiny battery features capabilities useful for biomedical applications, including powering drug molecule release and heart defibrillation (Yujia Zhang)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Scientists have invented a new type of biodegradable battery that could revolutionise robotics and transform the field of biomedical devices.

It is the first ever lithium-ion battery – the same type of battery found in everything from smartphones to solar energy storage systems – that is simultaneously high capacity, biodegradable, and capable of controlling remotely.

A team from the University of Oxford who developed the state-of-the-art device have already used it to control the beating and defibrillation of mouse hearts in the hope that it can be used to treat cardiac arrhythmia in humans.

“Cardiac arrhythmia is a leading cause of death worldwide,” said Professor Ming Lei, a senior electrophysiologist in cardiac arrhythmias at the University of Oxford.

“Our proof-of-concept application in animal models demonstrates an exciting new avenue of wireless and biodegradable devices for the management of arrhythmias.”

Constructed from biocompatible hydrogel droplets, the battery can operate within a living body without interfering with its physiology.

It could pave the way for the development of tiny smart devices, smaller than a few cubic millimetres, that are capable of interacting with biological tissues.

The scientists have filed a patent for the so-called soft battery, which also covers its use in small-scale robots for bioapplications.

“Our droplet battery is light-activated, rechargeable, and biodegradable after use. To date, it is the smallest hydrogel lithium-ion battery and has a superior energy density,” said Yujia Zhang from the University of Oxford’s Department of Chemistry, who led the research into the battery.

“We used the droplet battery to power the movement of charged molecules between synthetic cells and to control the beating and defibrillation of mouse hearts. By including magnetic particles to control movement, the battery can also function as a mobile energy carrier.”

The research was published in the journal Nature Chemical Engineering on Friday, in a study titled ‘A microscale soft lithium-ion battery for tissue stimulation’.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in